Sources | Names Used |
---|---|
GDSC1000 | KIN001-260 |
PharmacoGx | KIN001-260 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FCRLB | GDSC1000 | pan-cancer | AAC | -0.055 | 0.08 |
mRNA | GPD2 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.08 |
mRNA | RYR2 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.08 |
mRNA | MAP1A | GDSC1000 | pan-cancer | AAC | -0.06 | 0.08 |
mRNA | UBN2 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.08 |
mRNA | POMGNT1 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.08 |
mRNA | KLHL8 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.08 |
mRNA | GIMAP4 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.08 |
mRNA | LRPPRC | GDSC1000 | pan-cancer | AAC | 0.058 | 0.08 |
mRNA | RBM20 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.08 |